Matches in Wikidata for { <http://www.wikidata.org/entity/Q65541284> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q65541284 description "clinical trial" @default.
- Q65541284 description "ensayu clínicu" @default.
- Q65541284 description "klinisch onderzoek" @default.
- Q65541284 description "клінічне випробування" @default.
- Q65541284 name "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 name "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 type Item @default.
- Q65541284 label "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 label "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 prefLabel "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 prefLabel "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 P1050 Q65541284-B5501EC7-049F-4F70-86CC-5E2C33DB5B5C @default.
- Q65541284 P1132 Q65541284-D4AF999B-3C58-419E-A3D9-963036B331B2 @default.
- Q65541284 P1476 Q65541284-0615EA19-4AB0-459A-A587-CF7F2F2892F2 @default.
- Q65541284 P17 Q65541284-1201C8CF-5AC7-48CF-972A-2BE9971A4499 @default.
- Q65541284 P17 Q65541284-1A9FD246-5541-4EA8-A055-38E5BBC07D02 @default.
- Q65541284 P17 Q65541284-31AF8CD2-A612-463E-86AF-4BE4C3F59A05 @default.
- Q65541284 P17 Q65541284-5EF0EE69-4568-414E-87B1-112FA63CC0F4 @default.
- Q65541284 P17 Q65541284-79E73766-9143-4F61-A2F3-33BCA9A48037 @default.
- Q65541284 P17 Q65541284-90001C0F-B1A7-4D1E-BBBA-F7B999BDD003 @default.
- Q65541284 P17 Q65541284-9B40FD38-F89C-4C4B-919D-EA143A64A32A @default.
- Q65541284 P17 Q65541284-B51FF599-5925-498A-8A7C-5B215592C47C @default.
- Q65541284 P17 Q65541284-B5336E8F-9B07-459B-B957-AB7D37DA76C0 @default.
- Q65541284 P17 Q65541284-D9AD8033-3525-4853-9053-1C56B3068A11 @default.
- Q65541284 P17 Q65541284-EAF997ED-E2EF-49BC-9D18-DA8FD73272BA @default.
- Q65541284 P1813 Q65541284-28CD1571-62BC-419D-A5D6-D106D8657839 @default.
- Q65541284 P2899 Q65541284-0DC444E7-53B2-46C3-AC34-878763832F9E @default.
- Q65541284 P3098 Q65541284-B066AB33-7CC8-4826-9049-6F774A5A19D6 @default.
- Q65541284 P31 Q65541284-9C39F43D-BE08-4845-8572-60338DFED51B @default.
- Q65541284 P580 Q65541284-363DEB3F-8F4C-4BB4-BCC3-F44DE63B0EF7 @default.
- Q65541284 P582 Q65541284-F05FEF70-60B2-459C-A501-0B7A88ADB192 @default.
- Q65541284 P6099 Q65541284-2C2E97A8-1940-4021-8CCD-05F18D6889CC @default.
- Q65541284 P8363 Q65541284-8960F1C4-DFFB-4A24-A663-8C8A265A7DAE @default.
- Q65541284 P1050 Q170990 @default.
- Q65541284 P1132 "+444" @default.
- Q65541284 P1476 "A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Subjects With ActiveRheumatoid Arthritis Despite Methotrexate Therapy" @default.
- Q65541284 P17 Q16 @default.
- Q65541284 P17 Q183 @default.
- Q65541284 P17 Q28 @default.
- Q65541284 P17 Q298 @default.
- Q65541284 P17 Q30 @default.
- Q65541284 P17 Q36 @default.
- Q65541284 P17 Q408 @default.
- Q65541284 P17 Q414 @default.
- Q65541284 P17 Q664 @default.
- Q65541284 P17 Q865 @default.
- Q65541284 P17 Q96 @default.
- Q65541284 P1813 "GO-FORWARD" @default.
- Q65541284 P2899 "+18" @default.
- Q65541284 P3098 "NCT00264550" @default.
- Q65541284 P31 Q30612 @default.
- Q65541284 P580 "2005-12-01T00:00:00Z" @default.
- Q65541284 P582 "2007-09-01T00:00:00Z" @default.
- Q65541284 P6099 Q42824827 @default.
- Q65541284 P8363 Q78089383 @default.